Market Cap 22.34M
Revenue (ttm) 9.29M
Net Income (ttm) -40.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -437.78%
Debt to Equity Ratio 0.12
Volume 1,234,900
Avg Vol 1,626,182
Day's Range N/A - N/A
Shares Out 78.74M
Stochastic %K 12%
Beta 1.51
Analysts Strong Sell
Price Target $3.33

Company Profile

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States. Its lead drug product candidate is the CUE-401, a novel approach to induce and expand antigen specific Tregs for regulating disease causing autoreactive Teff cells which is in preclinical trial; and CUE-501, a treatment of autoimmune disease via anti-viral T cell-mediated depletion of B cells...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 949 2680
Address:
40 Guest Street, Boston, United States
LabPsycho
LabPsycho Mar. 18 at 6:40 PM
$CUE @Ron_Burn Nice call. This looks to me like yet another garden variety'biotech' using the over used move the past 4-5 years out of my yet to be published (hopefully) "BioGrifter's Wealth Transfer Vehicle Playbook" - May as well just dilute massively at your stock price's historical lows. There aint nothing your existing shareholders can do about it, so dilute, raise more $$$ for your salaries and benefits and be sure to chuckle while doing it.
0 · Reply
trading_momentum_x
trading_momentum_x Mar. 18 at 9:58 AM
$CUE Bias: Downtrend / choppy Levels: R: 0.30 → 0.32 S: 0.27 → 0.25 Alpha: Fail 0.30 → continuation lower. Reclaim → bounce scalp only.
0 · Reply
SirDuncan
SirDuncan Mar. 18 at 2:49 AM
$CUE just renewed all-time low
1 · Reply
VinWeezel
VinWeezel Mar. 17 at 7:37 PM
$CUE bert
0 · Reply
taneraydar
taneraydar Mar. 17 at 5:58 PM
$CUE in @.272 shouldn’t be that low.
1 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 2:43 PM
$CUE this is the low, rn... Once the $LNAI profit takers coming here, soon...
0 · Reply
Ron_Burn
Ron_Burn Mar. 17 at 1:41 PM
$CUE i smell dilution
0 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 12:24 PM
$CUE SHE BELONGS WAY HIGHER THEN THIS.. A*STAR IS A HUGE ENTITY. PARTNERSHIP WITH COLLABORATION.. $15MM+ 👍 ROYALTIES $$$ 👍 AHEAD.. LOW : $.23 PPS. HIGH : $1.05 PPS. BUSINESS ON GOING, ON TARGET, 👍 CONTINUATION ONWARD 👍 PT, RN: SUPER FUNG CHEAP 👍
0 · Reply
Ron_Burn
Ron_Burn Mar. 17 at 12:15 PM
$CUE she's my next play $LNAI
0 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 11:10 AM
$CUE ( A*STAR ) IS GIGANTIC ENTITY... 👍
0 · Reply
Latest News on CUE
Cue Biopharma Announces Pricing of $10 Million Public Offering

Dec 19, 2025, 8:00 AM EST - 3 months ago

Cue Biopharma Announces Pricing of $10 Million Public Offering


Cue Biopharma Announces Proposed Public Offering

Dec 18, 2025, 4:02 PM EST - 3 months ago

Cue Biopharma Announces Proposed Public Offering


Cue Biopharma to Host Virtual Investor Event on May 15, 2025

May 8, 2025, 8:00 AM EDT - 11 months ago

Cue Biopharma to Host Virtual Investor Event on May 15, 2025


Cue Biopharma, Inc. (CUE) Business Update Call (Transcript)

Apr 15, 2025, 6:12 PM EDT - 1 year ago

Cue Biopharma, Inc. (CUE) Business Update Call (Transcript)


Cue Biopharma to Host Business Update Call and Webcast

Apr 14, 2025, 5:02 PM EDT - 1 year ago

Cue Biopharma to Host Business Update Call and Webcast


Cue Biopharma Announces Strategic Organizational Transition

Nov 14, 2024, 8:00 AM EST - 1 year ago

Cue Biopharma Announces Strategic Organizational Transition


Cue Biopharma Announces Proposed Public Offering

Sep 26, 2024, 11:10 PM EDT - 1 year ago

Cue Biopharma Announces Proposed Public Offering


Cue Biopharma, Inc. (CUE) Q2 2024 Earnings Call Transcript

Aug 19, 2024, 8:17 PM EDT - 1 year ago

Cue Biopharma, Inc. (CUE) Q2 2024 Earnings Call Transcript


Cue Biopharma, Inc. (CUE) Q4 2023 Earnings Call Transcript

Apr 8, 2024, 9:43 PM EDT - 2 years ago

Cue Biopharma, Inc. (CUE) Q4 2023 Earnings Call Transcript


Cue Biopharma, Inc. (CUE) Q3 2023 Earnings Call Transcript

Nov 11, 2023, 3:32 PM EST - 2 years ago

Cue Biopharma, Inc. (CUE) Q3 2023 Earnings Call Transcript


Cue Biopharma, Inc. (CUE) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 10:23 PM EDT - 2 years ago

Cue Biopharma, Inc. (CUE) Q2 2023 Earnings Call Transcript


Cue Biopharma to Host Investor Call

Jun 7, 2023, 8:00 AM EDT - 3 years ago

Cue Biopharma to Host Investor Call


LabPsycho
LabPsycho Mar. 18 at 6:40 PM
$CUE @Ron_Burn Nice call. This looks to me like yet another garden variety'biotech' using the over used move the past 4-5 years out of my yet to be published (hopefully) "BioGrifter's Wealth Transfer Vehicle Playbook" - May as well just dilute massively at your stock price's historical lows. There aint nothing your existing shareholders can do about it, so dilute, raise more $$$ for your salaries and benefits and be sure to chuckle while doing it.
0 · Reply
trading_momentum_x
trading_momentum_x Mar. 18 at 9:58 AM
$CUE Bias: Downtrend / choppy Levels: R: 0.30 → 0.32 S: 0.27 → 0.25 Alpha: Fail 0.30 → continuation lower. Reclaim → bounce scalp only.
0 · Reply
SirDuncan
SirDuncan Mar. 18 at 2:49 AM
$CUE just renewed all-time low
1 · Reply
VinWeezel
VinWeezel Mar. 17 at 7:37 PM
$CUE bert
0 · Reply
taneraydar
taneraydar Mar. 17 at 5:58 PM
$CUE in @.272 shouldn’t be that low.
1 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 2:43 PM
$CUE this is the low, rn... Once the $LNAI profit takers coming here, soon...
0 · Reply
Ron_Burn
Ron_Burn Mar. 17 at 1:41 PM
$CUE i smell dilution
0 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 12:24 PM
$CUE SHE BELONGS WAY HIGHER THEN THIS.. A*STAR IS A HUGE ENTITY. PARTNERSHIP WITH COLLABORATION.. $15MM+ 👍 ROYALTIES $$$ 👍 AHEAD.. LOW : $.23 PPS. HIGH : $1.05 PPS. BUSINESS ON GOING, ON TARGET, 👍 CONTINUATION ONWARD 👍 PT, RN: SUPER FUNG CHEAP 👍
0 · Reply
Ron_Burn
Ron_Burn Mar. 17 at 12:15 PM
$CUE she's my next play $LNAI
0 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 11:10 AM
$CUE ( A*STAR ) IS GIGANTIC ENTITY... 👍
0 · Reply
Joyfulwood
Joyfulwood Mar. 17 at 9:39 AM
$CUE 0.29 dip SL under 0.26 Looking for consolidation near 0.30 PT 0.35/0.39/0.43/0.46/0.50+ Cue Biopharma Q4 And FY25 Collaboration Revenue Improves
0 · Reply
Ron_Burn
Ron_Burn Mar. 17 at 8:56 AM
$CUE possible entry here
0 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 7:26 AM
$CUE NO BS. JUST ROCK N ROLL TOMORROW 👍 #momo #fomo
0 · Reply
glaucio
glaucio Mar. 17 at 6:41 AM
$CUE crap 💩 stock, . They are going to receive 1 digit royalties 🤣. Presentation was on 14/3 and they released their crap news on @16/3 after market closed 🥴 short that crap as a hell.
0 · Reply
Ron_Burn
Ron_Burn Mar. 17 at 6:41 AM
$CUE no live charts in the o/n sucks, but i can still read the price action and fib levels. starter between 0.28 and 0.30, crossing 0.32 - 0.34 zone would send her on the next run
0 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 5:28 AM
$CUE 🔥 W 🔥 formation forming... THAT MEANS BALSTOFF ON THE WAY... Over 30-35x tomes over the daily volumes. LOOKING FOREARD TO MORNINGS CONTINUATION OF SLAPPAGE $$$... - Imo...
0 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 4:24 AM
$CUE SINGAPORE, November 13, 2025--(BUSINESS WIRE)--ImmunoScape Pte. Ltd., ( an A*STAR spin out backed by Amgen Ventures 👍 and EDBi ) 👈 that is developing next-generation TCR-based cancer immunotherapies, today announced an exclusive in-licensing deal with Cue Biopharma Inc. (Nasdaq: CUE) to lead the development of a distinct new class of therapies to attack solid tumor cancers. The deal provides ImmunoScape with exclusive access to Cue Biopharma’s clinical-stage Immuno-STAT® molecules in oncology 🔥
0 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 1:02 AM
$CUE YAHOO FINANCE SHOW: .36+ JUST NOW!
0 · Reply
Frab
Frab Mar. 17 at 1:02 AM
0 · Reply
SaySomethingNice
SaySomethingNice Mar. 17 at 12:11 AM
$CUE Some people likes to scare with words like RS talk.. The annual meeting is April 12 and the voting needs to be approve ??? Regardless, that's a few weeks away.. Non-issue and not urgency of that talk.. - Imo.. ( nfa )
0 · Reply
SirDuncan
SirDuncan Mar. 16 at 11:48 PM
$CUE very solid earnings, but a few things to remember: oncology progress was punted, autoimmune is still pre clinical with IND not yet approved, and a reverse split is proposed that will more than likely go into effect q2
0 · Reply
SaySomethingNice
SaySomethingNice Mar. 16 at 11:24 PM
$CUE 👀 👈 $CDIO $MBOT $HURA Take a look at the news... 52-WEEK HIGH : $1.05 PPS. 52-WEEK LOW: $.23 PPS. WE KNOW BIOTECH, WITH SOLID NEWS, OR ANY MONSTER NEWS, SHE'S GONE.. 👍
0 · Reply